Acute Pain Clinical Trials

Find Acute Pain Clinical Trials Near You

Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and Quality of Life After Surgical Extraction of Impacted Mandibular Third Molars

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

1. To compare the postoperative pain between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 2. To compare the postoperative swelling (edema) between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 3. To compare the degree of trismus between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 4. Measure patients' perceptions of changes in their quality of life in the postoperative period and compare it between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:

• Healthy patients over 18 years old of either gender.

• Patients who have impacted mandibular third molar.

• Ability to tolerate surgical procedure.

• Pell and Gregory's classification (Class I and class II, position A and B).

Locations
Other Locations
Iraq
Dunya Abdulmuniem Mahmood
RECRUITING
Baghdad
Contact Information
Primary
Dunya Abdulmuniem
duniamuniem@gmail.com
078018282446
Time Frame
Start Date: 2024-05-08
Estimated Completion Date: 2024-09-09
Participants
Target number of participants: 55
Treatments
Active_comparator: systemic proteolytic enzyme
Tibrolin combination of (Trypsin 48 mg, Bromelain 90 mg) and a bioflavonoid (Rutoside 100 mg) one by one for five day
Placebo_comparator: amoxicillin, metronidazol, doliprane
amoxicillin 500 mg one by three metronidazol 500 mg one by three doulprane 1000 mg one by one
Related Therapeutic Areas
Sponsors
Leads: University of Baghdad

This content was sourced from clinicaltrials.gov